199 related articles for article (PubMed ID: 23088865)
21. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study.
Galland BC; Tripp EG; Taylor BJ
J Sleep Res; 2010 Jun; 19(2):366-73. PubMed ID: 20050995
[TBL] [Abstract][Full Text] [Related]
22. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
23. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
24. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
Zhang HY; Du ML; Zhuang SQ; Liu MN
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
[TBL] [Abstract][Full Text] [Related]
25. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
26. Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.
Kordon A; Stollhoff K; Niederkirchner K; Mattejat F; Rettig K; Schäuble B
Postgrad Med; 2011 Sep; 123(5):27-38. PubMed ID: 21904084
[TBL] [Abstract][Full Text] [Related]
27. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
[TBL] [Abstract][Full Text] [Related]
28. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
[TBL] [Abstract][Full Text] [Related]
29. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder.
Nováková M; Paclt I; Ptáček R; Kuželová H; Hájek I; Sumová A
Chronobiol Int; 2011 Aug; 28(7):630-7. PubMed ID: 21859418
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
31. Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.
Isaksson J; Hogmark Å; Nilsson KW; Lindblad F
Psychiatry Res; 2013 Oct; 209(3):740-1. PubMed ID: 23850434
[TBL] [Abstract][Full Text] [Related]
32. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
33. Motor function and methylphenidate effect in children with attention deficit hyperactivity disorder.
Stray LL; Ellertsen B; Stray T
Acta Paediatr; 2010 Aug; 99(8):1199-204. PubMed ID: 20298494
[TBL] [Abstract][Full Text] [Related]
34. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
[TBL] [Abstract][Full Text] [Related]
35. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD.
Abikoff H; Nissley-Tsiopinis J; Gallagher R; Zambenedetti M; Seyffert M; Boorady R; McCarthy J
J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):166-75. PubMed ID: 19127171
[TBL] [Abstract][Full Text] [Related]
36. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions.
Musten LM; Firestone P; Pisterman S; Bennett S; Mercer J
J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1407-15. PubMed ID: 9334554
[TBL] [Abstract][Full Text] [Related]
37. [Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate].
Dura-Trave T; Yoldi-Petri ME; Zardoya-Santos P
Rev Neurol; 2011 Sep; 53(5):257-64. PubMed ID: 21796603
[TBL] [Abstract][Full Text] [Related]
38. Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder.
Sahin S; Yuce M; Alacam H; Karabekiroglu K; Say GN; Salıs O
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):280-7. PubMed ID: 24994482
[TBL] [Abstract][Full Text] [Related]
39. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology.
Fernández-López L; Molina-Carballo A; Cubero-Millán I; Checa-Ros A; Machado-Casas I; Blanca-Jover E; Jerez-Calero A; Madrid-Fernández Y; Uberos J; Muñoz-Hoyos A
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):177-188. PubMed ID: 32048862
[No Abstract] [Full Text] [Related]
40. Single-dose pharmacokinetics of NWP06, an extended-release methylphenidate suspension, in children and adolescents with ADHD.
Childress AC; Sallee FR; Berry SA
Postgrad Med; 2011 Sep; 123(5):80-8. PubMed ID: 21904089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
